Eagle Pharmaceuticals, Inc. Operating Lease, Liability, Current
Eagle Pharmaceuticals, Inc. had Operating Lease, Liability, Current of $1.42 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2023-08-09
- 2023-06-30: Operating Lease, Liability, Current $1.42M.
- 2023-03-31: Operating Lease, Liability, Current $1.59M.
- 2022-12-31: Operating Lease, Liability, Current $1.53M.
- 2022-09-30: Operating Lease, Liability, Current $1.51M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-06-30 | $1.42M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $1.59M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.53M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $1.51M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.48M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.31M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.15M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.12M 10-K · filed 2022-03-08 |
| 2020-09-30 | $1.12M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.11M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.27M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.10M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $1.08M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $1.05M 10-Q · filed 2019-08-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 |